Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q1 2018 Earnings

8FebConfirmed

Q2 2017

Q3 2017

Q4 2017

Q1 2018

-4.86

-4.46

-4.06

-3.66

Details

Expected EPS

-4.5650379999999995

Actual EPS

-4.860615999999999

Surprise EPS

-0.3

Surprise Percent

+6.47%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -4.860615999999999 per share for Q1 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.